🔥 The Breaking News

On April 7, 2026, Vietnam officially launched the Vietnam Medical Tourism Alliance (VMTA) in Hanoi — a landmark move positioning the country as a future global hub for integrated medical tourism. The alliance brings together stakeholders from healthcare, tourism, technology, and finance under the orientation of Vietnam's National Authority of Tourism and the Ministry of Health's Department of Medical Service Administration.

The VMTA's stated mission is twofold: first, to keep Vietnamese patients who currently seek treatment abroad — spending an estimated $2–3 billion annually — within the domestic healthcare system; second, to attract international medical tourists, particularly from neighboring Cambodia, Laos, and Myanmar, as well as Russian and Middle Eastern visitors seeking quality care at accessible prices.

"We want to make Vietnam a leading integrated medical tourism hub globally, where healthcare, tourism, finance, and technology are connected within a unified, modern, and internationally standardized ecosystem," said Ha Anh Duc, head of the Department of Medical Service Administration at the launch ceremony.

Why This Matters: Vietnam's push into medical tourism comes as the global medical tourism market is projected to hit $312 billion in 2026. With countries across Asia competing for a larger share, Vietnam is betting that a coordinated national strategy can carve out a niche — even as regional giants like China, Thailand, and Singapore have established head starts.

🏥 China's Healthcare System Today

China, meanwhile, is pursuing its own medical tourism strategy — with a very different scale and approach. While Vietnam is just launching its alliance, China has been building its medical tourism infrastructure for years.

The Hainan Boao Lecheng International Medical Tourism Pilot Zone, established in 2013, has become the center of China's medical tourism ambitions. This special zone allows the use of imported drugs and medical devices not yet approved elsewhere in China, a major draw for patients seeking the latest treatments. The region has also benefited from the "Hello! China 2026" tourism initiative, which launched earlier this year with medical tourism and Traditional Chinese Medicine (TCM) wellness as core strategic pillars.

Chinese hospitals, particularly tier-1 institutions like Peking Union Medical College Hospital, West China Hospital, and Shanghai Ruijin Hospital, have set up dedicated international patient departments. These facilities handle a growing volume of foreign patients from Southeast Asia, the Middle East, and recently Japan. Some northern Japanese patients have been turning to Chinese hospitals for advanced treatment like proton therapy and specialized cancer surgery, as Japan-China relations remain strained.

China's approach differs from Vietnam's in another key way: technology. As highlighted at the 93rd CMEF opening in Shanghai this week (April 9-12), Chinese hospitals are deploying surgical robots and remote surgery capabilities that enable foreign doctors to operate on patients in their home countries from thousands of kilometers away. This level of technological sophistication is something Vietnam's developing system is years away from matching.

📊 Comparison: Vietnam vs China Medical Tourism

Factor Vietnam China
National Strategy VMTA launched April 2026; early-stage coordination across sectors Well-established infrastructure, Hainan pilot zone since 2013, TCM integration
Medical Specialties Focus on basic to intermediate procedures: dental, cosmetic, basic orthopedics Advanced oncology, cardiac surgery, neurosurgery, proton therapy, TCM integration
Technology Level Developing; basic robotics and telemedicine in early phases Surgical robots, remote surgery, AI diagnostics, precision medicine
Cost Advantage Low: procedures often 40-60% below regional averages Moderate: 40-70% below US/EU costs, though higher than Thailand or Vietnam for basic care
Target Markets Cambodia, Laos, Myanmar, Russia, Middle East; domestic patients Global, growing from SE Asia, Middle East, Japan, US, Europe
International Patients (est.) About 100,000 annually, mostly from regional neighbors. Target: 1 million by 2030 More than 500,000 annually. Projected to exceed 1 million by 2027
Waiting Time Very short for basic procedures: 1-3 days for consultations Short at private international departments: 1-5 days for specialist appointments
JCI-Accredited Hospitals About 6 hospitals currently accredited Over 100 JCI-accredited facilities, concentrated in tier-1 cities
Language Support English available at major hospitals, limited multilingual staff Strong at international departments: English, Arabic, Russian widely available

💡 Key Takeaways

  • Vietnam is a newcomer with potential. The VMTA launch is a promising step, but Vietnam's medical tourism industry remains in early stages compared to regional competitors.
  • China offers greater depth and range. For complex conditions — cancer, cardiac disease, neurological disorders — China's tier-1 hospitals provide capabilities that Vietnam simply cannot match yet.
  • For budget-conscious basic care, Vietnam may have an edge. Dental work, cosmetic procedures, and straightforward orthopedic surgeries in Vietnam come at rock-bottom prices with minimal wait times.
  • China's advantage is integration. Patients seeking to combine advanced Western medicine with Traditional Chinese Medicine wellness therapies will find China's system far more mature.
  • Vietnam's real competition is Thailand, not China. For basic medical tourism, Vietnam competes directly with Thailand's established brand — a tougher fight than it might initially seem.

🔗 Related Information

📚 Sources

Considering Medical Treatment in China?

Our coordination team connects international patients with the right specialists across China's top hospitals. Get a free consultation within 24 hours.

Get a Free Consultation →